The increased circulating TCC in the IRDCAD (SLE and RA) group reflects increased basic complement activation [14], and may be mediated by increased levels of PTX3, which is known to regulate complement activation.[15]. The gene discussed is PTX3; the disease is systemic lupus erythematosus.